🇺🇸 Glyclazide in United States

23 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 3 reports (13.04%)
  2. Weight Decreased — 3 reports (13.04%)
  3. Weight Increased — 3 reports (13.04%)
  4. Anaemia — 2 reports (8.7%)
  5. Blood Glucose Decreased — 2 reports (8.7%)
  6. Blood Pressure Increased — 2 reports (8.7%)
  7. Death — 2 reports (8.7%)
  8. Depression — 2 reports (8.7%)
  9. Diarrhoea — 2 reports (8.7%)
  10. Drug Ineffective — 2 reports (8.7%)

Source database →

Other Metabolic approved in United States

Frequently asked questions

Is Glyclazide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glyclazide in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.